{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:13:23Z","timestamp":1780409603914,"version":"3.54.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Combined central and peripheral demyelination (CCPD) is an extremely rare disease characterized by inflammatory demyelination in both the central and peripheral nervous systems. Herein, we reported case of a 14-year-old teenager who initially presented with the symptoms of acute myelitis (AM). Subsequently, the patient developed symptoms consistent with Guillain-Barr\u00e9 syndrome (GBS), which was supported by nerve conduction studies (NCV) and cerebrospinal fluid (CSF) analysis. Throughout the course of the disease, the patient experienced abdominal pain and abnormal liver function. After a comprehensive evaluation, we determined that the abnormal liver function was a result of hepatitis E virus (HEV) infection, which may have acted as a trigger for GBS. The patient was treated with corticosteroids, intravenous immunoglobulin and Rituximab, resulting in symptom relief and clinical improvement after therapy and follow-up. This case highlights the potential responsiveness and reversibility of CCPD. Given the heterogeneous nature of CCPD, there is currently no standardized diagnostic criteria or clear consensus on its treatment. Therefore, we recommend a thorough assessment of all possibilities and the development of consolidated management guidelines based on available data for this disorder.<\/jats:p>","DOI":"10.3389\/fneur.2023.1288546","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:14:12Z","timestamp":1705378452000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Combined central and peripheral demyelination: a case report resembling encephalomyeloradiculoneuropathy"],"prefix":"10.3389","volume":"14","author":[{"given":"Xuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jns.2016.02.022","article-title":"Combined central and peripheral demyelination: clinical features, diagnostic findings, and treatment","volume":"363","author":"Cortese","year":"2016","journal-title":"J Neurol Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/brain\/110.1.53","article-title":"Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination","volume":"110","author":"Thomas","year":"1987","journal-title":"Brain"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1136\/jnnp.2006.108290","article-title":"Relapsing demyelinating disease affecting both the central and peripheral nervous systems","volume":"79","author":"Z\u00e9phir","year":"2008","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"730129","DOI":"10.3389\/fneur.2021.730129","article-title":"A new report of combined central and peripheral demyelination: a case report","volume":"12","author":"Alshamrani","year":"2021","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"jnnp-2014-309831","DOI":"10.1136\/jnnp-2014-309831","article-title":"A nationwide survey of combined central and peripheral demyelination in Japan","volume":"87","author":"Ogata","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","article-title":"Guillain-Barr\u00e9 syndrome","volume":"352","author":"Hahn","year":"1998","journal-title":"Lancet"},{"key":"ref9","first-page":"230","article-title":"Guillain-Barr\u00e9 syndrome and its association with infectious factors","volume":"39","author":"Grygorczuk","year":"2005","journal-title":"Neurol Neurochir Pol"},{"key":"ref10","first-page":"216","article-title":"Guillain-Barre syndrome associated with acute hepatitis E","volume":"24","author":"Kamani","year":"2005","journal-title":"Indian J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s15010-011-0185-6","article-title":"First case of anti-ganglioside GM1-positive Guillain-Barr\u00e9 syndrome due to hepatitis E virus infection","volume":"40","author":"Maurissen","year":"2012","journal-title":"Infection"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jocn.2011.06.024","article-title":"Guillain-Barr\u00e9 syndrome associated with acute hepatitis E infection","volume":"19","author":"Tse","year":"2012","journal-title":"J Clin Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10072-014-1731-7","article-title":"Guillain-Barr\u00e9 syndrome and encephalitis\/encephalopathy of a rare case of northern China acute severe hepatitis E infection","volume":"35","author":"Chen","year":"2014","journal-title":"Neurol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/jamaneurol.2016.3541","article-title":"Diagnostic challenges and clinical characteristics of hepatitis E virus-associated Guillain-Barr\u00e9 syndrome","volume":"74","author":"Stevens","year":"2017","journal-title":"J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/cit512","article-title":"Hepatitis E and Guillain-Barre syndrome","volume":"57","author":"Geurtsvankessel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/jvh.12515","article-title":"Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells","volume":"23","author":"Drave","year":"2016","journal-title":"J Viral Hepat"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","article-title":"Guillain-Barr\u00e9 syndrome associated with preceding hepatitis E virus infection","volume":"82","author":"van den Berg","year":"2014","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s10072-016-2644-4","article-title":"Guillain-Barr\u00e9 and miller fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan","volume":"37","author":"Fukae","year":"2016","journal-title":"Neurol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"102926","DOI":"10.1016\/j.msard.2021.102926","article-title":"Atypical inflammatory demyelinating syndrome with central and peripheral nerve involvement","volume":"51","author":"Farag","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2007.01.004","article-title":"A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy","volume":"255","author":"Pineda","year":"2007","journal-title":"J Neurol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/jamaneurol.2017.4011","article-title":"Comparative effectiveness of rituximab and other initial treatment choices for multiple sclerosis","volume":"75","author":"Granqvist","year":"2018","journal-title":"JAMA Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.5692\/clinicalneurol.cn-000977","article-title":"Efficacy of high-dose steroid pulse therapy for anti-galactocerebroside antibody-positive combined central and peripheral demyelination","volume":"57","author":"Hoshino","year":"2017","journal-title":"Rinsho Shinkeigaku"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clineuro.2018.06.046","article-title":"Anti-neutral glycolipids antibody-positive combined central and peripheral demyelination mimicking encephalomyeloradiculoneuropathy phenotype","volume":"172","author":"Saito","year":"2018","journal-title":"Clin"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000000015","article-title":"Anti-neutral glycolipid antibodies in encephalomyeloradiculoneuropathy","volume":"82","author":"Shima","year":"2014","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fneur.2018.00206","article-title":"A patient with encephalomyeloradiculoneuropathy exhibiting a relapsing-remitting clinical course: correlation of serum and cerebrospinal fluid anti-neutral glycosphingolipids antibodies with clinical relapse","volume":"9","author":"Nanaura","year":"2018","journal-title":"Front Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/2211-5463.13578","article-title":"Sphingolipid abnormalities in encephalomyeloradiculoneuropathy (EMRN) are associated with an anti-neutral glycolipid antibody","volume":"13","author":"Mutoh","year":"2023","journal-title":"FEBS Open Bio"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e10198","DOI":"10.1016\/j.heliyon.2022.e10198","article-title":"The first pediatric anti-lactosylceramide antibody-positive encephalomyeloradiculoneuropathy","volume":"8","author":"Sasaki","year":"2022","journal-title":"Heliyon"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1288546\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:14:15Z","timestamp":1705378455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1288546\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":28,"alternative-id":["10.3389\/fneur.2023.1288546"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1288546","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"article-number":"1288546"}}